Magnetic brain stimulation aids motor function, balance in MS trial
Coupling a noninvasive brain stimulation procedure with an intensive rehabilitation program significantly improved motor function and balance in adults with…
Articles by Steve Bryson, PhD
MS trial to test magnetic brain stimulation for overactive bladder
A small clinical trial in Texas is testing whether a noninvasive magnetic brain stimulation procedure can ease the symptoms of…
Non-invasive MEG scan can predict cognitive therapy outcomes in MS
A non-invasive scan that measures network activity across the brain was able to predict the outcomes of behavioral therapies designed…
Barancik Prize for Innovation in MS Research goes to UCSF scientist
Sergio E. Baranzini, PhD, a scientist at the University of California, San Francisco (UCSF), is this year’s winner of the…
Ibudilast slows growth of chronic brain lesions tied to worsening MS
Use of oral ibudilast — being explored as a treatment for progressive forms of multiple sclerosis (MS) — was…
Blood levels of GFAP protein may predict disease progression in PPMS
The ongoing worsening of disability among people with primary progressive multiple sclerosis (PPMS) may be predicted by elevated blood…
Ocrevus in real world may also help severely disabled MS patients
Treatment with Ocrevus (ocrelizumab) may stabilize disability progression in people with multiple sclerosis (MS) who have severe walking…
Age of onset of RRMS increased in Norway over past century: Study
An increasing number of people in western Norway have been diagnosed with relapsing-remitting multiple sclerosis (RRMS) after age 50 over…
New AI algorithm provides better MRI images of brain in MS: Study
DeepSTI, a new artificial intelligence or AI-assisted MRI algorithm, can generate high-resolution, 3D images of the brain from only one…
Sedentary behaviors more common among MS patients: 11 studies
People with multiple sclerosis (MS) engage in significantly more sedentary behaviors — activities like watching TV or using a…
Extending Tysabri dose intervals controls RRMS activity
Extending Tysabri (natalizumab) dosing intervals based on the drug’s blood levels was as effective at controlling disease activity in…
Vumerity reduces relapses, lesions over 2 years: EVOLVE-MS-1 study
Nearly two years of treatment with Vumerity (diroximel fumarate) significantly reduced relapse rates by more than 80% in people…
iConquerMS expands research efforts to focus on MS caregivers
iConquerMS, a research initiative where people affected by multiple sclerosis (MS) contribute their health data and ideas, is…
Blood test for antibody clumps may support MS diagnosis
Measuring the amount of specific antibody clumps in the blood helped distinguish people with multiple sclerosis (MS) from healthy…
Noninvasive brain stimulation may help with walking ability: Analysis
A noninvasive brain stimulation technique called transcranial direct current stimulation (tDCS) can significantly improve walking abilities in people with…
EBV vaccine expected to be cost-effective in preventing MS: Study
Using a vaccine against the Epstein-Barr virus (EBV) to prevent the development of multiple sclerosis (MS) is highly likely…
Less restrictive low-fat diet seen to lessen fatigue in MS: Pilot study
Adhering to a low-fat diet for three months was found to significantly ease fatigue among people with multiple sclerosis…
ChariotMS trial of Mavenclad in UK enrolls 100 progressive MS patients
ChariotMS, the world’s first clinical trial to test whether Mavenclad (cladribine) can slow the worsening of upper limb function…
Menopause linked with lower MS relapse rate, increased disability
Women with multiple sclerosis (MS) have significantly lower relapse rates after entering menopause, but disability levels increase significantly in…
Rehabilitation in progressive MS found to help cognitive function
Two non-pharmacological rehabilitation approaches — one using a computer program designed to improve working memory and the other involving standardized…
No greater risk of hospitalization found after vaccines in MS in study
People with multiple sclerosis (MS) who receive vaccines against influenza — commonly known as flu shots — as well…
Octave to test its precision MS care program in real-world study
Octave Bioscience plans to test its precision care program in an observational, real-world study with people with multiple…
Innodem, Novartis agree to continue developing eye-tracking technology
Innodem Neurosciences has signed a multi-year agreement with Novartis Canada to continue developing Innodem’s digital biomarker eye-tracking technology,…
GFAP protein levels in blood fail to predict disease progression in RRMS
Levels of GFAP protein in the blood — a marker of damage to support cells in the brain — were…
Pilates with relaxation improves walking, self-awareness in MS
Pilates exercise with a relaxation technique improved walking abilities and self-awareness among people with multiple sclerosis (MS), according to…
Walking loss more rapid among marginalized MS patients in US
People with multiple sclerosis (MS) with a rapid decline in walking abilities were more likely to be older when…
US neurologists satisfied with current RRMS therapies: Report
Neurologists in the U.S. are largely satisfied with current treatment options for relapsing-remitting multiple sclerosis (RRMS), but opportunities remain…
Vitamin D supplement reduces progressive MS disease in rats
Vitamin D reduced the signs of inflammation and nerve damage in a rat model of progressive multiple sclerosis (MS),…
NfL blood test may detect neurodegeneration in youngsters
Neurofilament light chain (NfL) protein levels can be used to assess neurodegeneration in children and adolescents with neurological disease, including…
Tecfidera confirmed safe, effective in Black and Hispanic MS patients
Treatment with Tecfidera (dimethyl fumarate) provides a similar long-term benefit for Black and Hispanic people with multiple sclerosis…